Navalign LLC’s Medtronic MDT Stock Holding History

Navalign LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-66	Closed	-$6.34K	–	332
2025 Q4	$6.34K	Buy	+66	New	+$6.41K	﹤0.01%	371

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Navalign LLC's MDT Position: Q1 2026 in Review

Navalign LLC sold out of Medtronic (MDT) in Q1 2026, closing a stake of 66 shares — an estimated $6.34K sold.

Navalign LLC first reported a position in MDT in Q4 2025 and held it in 1 quarter. The position peaked at $6.34K in Q4 2025. 2,237 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Navalign LLC reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 66 Medtronic shares in Q1 2026, an estimated $6.34K.
Navalign LLC first reported a position in Medtronic in Q4 2025 and held it in 1 quarter.
Navalign LLC's Medtronic position peaked at $6.34K in Q4 2025.
2,237 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.